Literature DB >> 326545

Metabolism of valproate sodium in rabbit, rat, dog, and man.

B Ferrandes, P Eymard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 326545     DOI: 10.1111/j.1528-1157.1977.tb04465.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


× No keyword cloud information.
  7 in total

Review 1.  Methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteins.

Authors:  J P Tillement; E Albengres; S Urien
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

Review 2.  Clinical pharmacokinetics of valproic acid.

Authors:  R Gugler; G E von Unruh
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

Review 3.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

4.  A dual role for GABA in quasi-morphine abstinence behavior induced by di-n-propylacetate involving both initiation and termination.

Authors:  J W Van der Laan; J Bruinvels
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  The influence of free fatty acids on valproic acid plasma protein binding during fasting in normal humans.

Authors:  T A Bowdle; I H Patel; R H Levy; A J Wilensky
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

6.  The interaction of denzimol (a new anticonvulsant) with carbamazepine and phenytoin.

Authors:  P N Patsalos; S D Shorvon; A A Elyas; G Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-04       Impact factor: 10.154

Review 7.  Clinical pharmacokinetics of valproic acid--1988.

Authors:  G Zaccara; A Messori; F Moroni
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.